The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX ® Testing.

Bradley M TurnerBrian S FinkelmanDavid G HicksNumbere NumbereyeIoana MoisiniAjay DhakalKristin SkinnerMary Ann G SandersXi WangMichelle ShayneLinda SchiffhauerHani KaterjiHuina Zhang

Published in: Cancers (2023)

. The RoMMa can be helpful in the initial clinical risk-assessment and risk-stratification of BC patients, providing increased opportunities for cost savings in the health care system, and for clinical risk-assessment and risk-stratification in less-developed geographies where multigene testing might not be available.

Keyphrases

risk assessment
human health
heavy metals
end stage renal disease
chronic kidney disease
machine learning
deep learning
insulin resistance
weight loss